BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grandics P. The cancer stem cell: evidence for its origin as an injured autoreactive T cell. Mol Cancer. 2006;5:6. [PMID: 16478542 DOI: 10.1186/1476-4598-5-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhuang Z, Cai H, Lin H, Guan B, Wu Y, Zhang Y, Liu X, Zhuang J, Guan G. Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer. J Oncol 2021;2021:5818512. [PMID: 34840571 DOI: 10.1155/2021/5818512] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
2 Prabavathy D, Swarnalatha Y, Ramadoss N. Lung cancer stem cells-origin, characteristics and therapy. Stem Cell Investig. 2018;5:6. [PMID: 29682513 DOI: 10.21037/sci.2018.02.01] [Cited by in Crossref: 27] [Cited by in F6Publishing: 46] [Article Influence: 6.8] [Reference Citation Analysis]
3 Monajemzadeh M, Soleimani V, Vasei M, Koochakzadeh L, Karbakhsh M. Expression and prognostic significance of Oct4 and Nanog in neuroblastoma. APMIS 2014;122:734-41. [PMID: 24320714 DOI: 10.1111/apm.12207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
4 Schittenhelm J, Simon P, Harter PN, Zachskorn C, Schlaszus H, Röttger F, Winkels M, Weller M, Meyermann R, Mittelbronn M. CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms: CD133 in CNS neoplasms. Histopathology 2011;58:739-49. [DOI: 10.1111/j.1365-2559.2011.03801.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
5 Hide T, Takezaki T, Nakamura H, Kuratsu J, Kondo T. Brain tumor stem cells as research and treatment targets. Brain Tumor Pathol 2008;25:67-72. [DOI: 10.1007/s10014-008-0237-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
6 Murphy GF. Target cells in graft-versus-host disease: implications for cancer therapy. Clin Rev Allergy Immunol 2007;33:113-23. [PMID: 18094950 DOI: 10.1007/s12016-007-0028-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Arias JI, Aller MA, Arias J. Cancer cell: using inflammation to invade the host. Mol Cancer 2007;6:29. [PMID: 17437633 DOI: 10.1186/1476-4598-6-29] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
8 Liu W, Mao SY, Zhu WY. Impact of tiny miRNAs on cancers. World J Gastroenterol 2007; 13(4): 497-502 [PMID: 17278213 DOI: 10.3748/wjg.v13.i4.497] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
9 Oppenheimer SB. Cellular basis of cancer metastasis: A review of fundamentals and new advances. Acta Histochem 2006;108:327-34. [PMID: 16730054 DOI: 10.1016/j.acthis.2006.03.008] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]